輝瑞 CEO：到 2025 年計劃在華提交 12 款創新藥上市申請

華爾街見聞
2023.03.25 05:03
3 月 25 日，在中國發展高層論壇 2023 年年會論壇上，輝瑞公司董事長、首席執行官艾伯樂表示，2022 年，輝瑞有 11 個新產品和新適應症獲批上市，從現在起到 2025 年，輝瑞計劃在華提交約 12 款創新藥物的上市申請。（澎湃新聞）
Source: 華爾街見聞 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.